Smartlens, Inc.

Smartlens, Inc. is an ophthalmic technology company specializing in the development of innovative solutions for diagnosing and treating anterior segment eye diseases. With a strong focus on addressing unmet needs in ophthalmology, the company’s pipeline includes miLens, a novel soft contact lens that enables continuous monitoring of intraocular pressure (IOP) in patients living with glaucoma and ocular hypertension. For more information, please visit www.smartlens.health



Office Locations
Sunnyvale, California
Contact Information
[email protected]
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.

Latest

Oct 14, 2025, 09:41 ET Smartlens, Inc. Secures $5.2 Million Bridge Round to Advance FDA Clearance Process and Prepare for Commercial Launch of miLens

Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, today announced the closing of ...

Jul 11, 2023, 09:09 ET Smartlens, Inc. Closes $6.1M Series A led by Ambit Health Ventures with investments from prominent institutions and Stanford University

Smartlens, Inc., a clinical-stage ophthalmic technology company, has closed an oversubscribed $6.1M Series A equity financing round to advance...

May 03, 2023, 09:05 ET Smartlens, Inc. Announces Positive Clinical Results for miLens, a Novel, Soft Contact Lens for Monitoring Intraocular Pressure

Smartlens, Inc., a clinical-stage ophthalmic technology company, has announced positive clinical results for miLens, a non-invasive,...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.